CHOP Researchers Discover Key Metabolic Process Responsible for Rapid Immune Responses
Published on
A metabolite called NAD encourages immune cells to divide more quickly and could be used to improve efficacy of cell-based therapies.
Published on
A metabolite called NAD encourages immune cells to divide more quickly and could be used to improve efficacy of cell-based therapies.
Published on
All three genes had variants affecting splicing and resulted in symptoms like developmental delays, intellectual disability, hypotonia, seizures and autism.
Published on
A new study by researchers at CHOP and Penn has identified an important role for a non-classical MHC molecule that engages with a cryptic viral peptide derived from influenza A virus.
Published on
CHOP researchers have developed a computational tool to determine which cells in patient tumor samples receive mitochondria from T cells.
Published on
CHOP researchers have developed a versatile and low-cost technology for targeted sequencing of full-length RNA molecules.
Published on
CHOP researchers have shown that NSAIDs disrupt epithelial cells in the colon and sensitize them to C. difficile toxins by perturbing cell mitochondria.
Published on
CHOP researchers have engineered stable, universal MHC-I molecules that can be produced rapidly at scale, allowing researchers to develop vaccines and immunotherapies more quickly.
Published on
CHOP and UCLA researchers have created a tool that can discover tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.
Published on
CHOP researchers have shown that adenovirus proteins use a process called phase separation to coordinate production of viral progeny, which could have broad implications.
Published on
CHOP researchers have found that Enterococcus – an antibiotic-resistant, opportunistic pathogen – works together with C. difficile, reshaping and enhancing the metabolic environment in the gut so that C. difficile can thrive.